In the News
Avoiding Chemo: Two Promising Drugs Go Head-to-Head in New Clinical Trial
Gateway for Cancer Research accelerates practice-changing clinical trials to cancer research by harnessing the unrelenting passion of the research community and empowering patients to triumph over their disease. All of this is guided by a clear vision: To shape a world in which a cancer diagnosis is no longer feared.
Combination Slows Metastatic CRC Progression Better Than Single Immunotherapy
An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression versus a single drug, according to a randomized study.
Botensilimab Plus Balstilimab Elicits Encouraging Responses in MSS mCRC Without Liver Mets
Balstilimab and botensilimab combination therapy showed superior efficacy in MSS mCRC patients without liver metastases compared to botensilimab monotherapy.
Redefining Cancer Care
Harnessing the power of the immune system, Agenus Bio leads the charge in immuno-oncology.
I never knew how close to this disease I would eventually become – Benny Johnson’s personal story with cancer
The new issue of OncoDaily Magazine had the privilege to feature an exclusive interview with Dr. Benny Johnson, Senior Medical Director at Agenus, discussing his career and dedication to oncology, his motivation, professional vision for emerging treatments and personal experiences with cancer.
Neoadjuvant Botensilimab/Balstilimab Is Active in Resectable Colon Cancer, Despite MMR Status
Botensilimab and balstilimab demonstrated pathological responses across subsets of patients with resectable colon cancer.